Relapse Rates and Symptom Management Among Patients Receiving Natalizumab and other Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.464
https://www.valueinhealthjournal.com/article/S1098-3015(16)31831-9/fulltext
Title : Relapse Rates and Symptom Management Among Patients Receiving Natalizumab and other Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31831-9&doi=10.1016/j.jval.2016.09.464
First page : A427
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 441
Categories :
Tags :
Regions :
ViH Article Tags :